Rovio Entertainment Corporation Stock Exchange Release August 22, 2023 at 1.00 p.m. EET Notice to the Extraordinary General Meeting of Rovio Entertainment Corporation Notice.
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement